To identify novel antitrypanosomal agents based on Janadolide, a potent macrocyclic polyketide-peptide hybrid, a macrolactonization strategy was explored. We prepared des--butyl Janadolide and evaluated its antitrypanosomal activity. Our findings suggest that the -butyl group is necessary for the desired bioactivity.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044843 | PMC |
http://dx.doi.org/10.1021/acsomega.7b01920 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!